Recent Updates
Recently added Catalysts
XENE Positive Sentiment Score: 70/100

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Thursday, April 4, 2024 1 min read
Key Takeaway: Xenon Pharmaceuticals Inc. has announced its participation in the 23rd Annual Needham Virtual Healthcare Conference scheduled for April 8-11, 2024. Ian Mortimer, the company's President and CEO, along with CFO Sherry Aulin, will present on April 11, 2024. A live webcast of the presentation will be accessible on the company’s website, providing an opportunity for investors and stakeholders to hear directly from the company’s leadership. Xenon focuses on addressing high unmet medical needs in neurology and psychiatry.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xenon Pharmaceuticals is actively engaging in investor relations by presenting at a significant healthcare conference.
  • The company is focused on developing innovative therapeutics for neurological and psychiatric disorders.
  • Leadership presence, including the CEO and CFO, indicates a commitment to transparency and investor engagement.

Full Press Release Details

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024.
Company Fireside Chat Presentation Details:
Date: Thursday, April 11, 2024
Time: 3:00 PM Eastern Time
Webcast: Register here
Presenters: Ian Mortimer, President and Chief Executive Officer
Sherry Aulin, Chief Financial Officer
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Vice President, Investor Relations
investors@xenon-pharma.com
Xenon Corporate Affairs
media@xenon-pharma.com

Frequently Asked Questions

When will Xenon Pharmaceuticals present at the Needham Healthcare Conference?

Xenon Pharmaceuticals will present on April 11, 2024, at 3:00 PM ET.

Who will be presenting for Xenon Pharmaceuticals?

Ian Mortimer and Sherry Aulin will represent Xenon Pharmaceuticals.

Where can I watch Xenon's conference presentation?

The presentation will be available via live webcast on Xenon's website.

What is Xenon Pharmaceuticals focused on?

Xenon Pharmaceuticals focuses on developing therapies for neurological disorders.

What disorders does Xenon address with its products?

Xenon targets epilepsy and depression among other neurological conditions.

Tags: XENE Viatris Investor Conferences Healthcare XEN Xenon Pharmaceuticals healthcare conference neurology psychiatry
Last updated: Apr 4, 2024